Cargando…

Protein-Based Nanoparticle Vaccines for SARS-CoV-2

The pandemic caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has upended healthcare systems and economies around the world. Rapid understanding of the structural biology and pathogenesis of SARS-CoV-2 has allowed the development of emergency use or FDA-approved vaccines an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sung, Hyo-Dong, Kim, Nayeon, Lee, Yeram, Lee, Eun Jung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703262/ https://www.ncbi.nlm.nih.gov/pubmed/34948241 http://dx.doi.org/10.3390/ijms222413445

Ejemplares similares

A Multivalent Vaccine Based on Ferritin Nanocage Elicits Potent Protective Immune Responses against SARS-CoV-2 Mutations
por: Kim, Seong A., et al.
Publicado: (2022)

Immunogenicity of candidate SARS-CoV-2 DNA vaccines based on the spike protein
por: Lim, Heeji, et al.
Publicado: (2022)

Retinal Hemorrhage after SARS-CoV-2 Vaccination
por: Park, Hyo Song, et al.
Publicado: (2021)

Comparison of Six Serological Immunoassays for the Detection of SARS-CoV-2 Neutralizing Antibody Levels in the Vaccinated Population
por: Lee, Hee-Jung, et al.
Publicado: (2022)

Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
por: Huh, Jung Eun, et al.
Publicado: (2021)

An Exploration of Nanoparticle-Based Diagnostic Approaches for Coronaviruses: SARS-CoV-2, SARS-CoV and MERS-CoV
por: Al-Hindawi, Ahmed, et al.
Publicado: (2022)

Recombinant measles virus encoding the spike protein of SARS-CoV-2 efficiently induces Th1 responses and neutralizing antibodies that block SARS-CoV-2 variants
por: Kwak, Hye Won, et al.
Publicado: (2023)

Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2
por: Walls, Alexandra C., et al.
Publicado: (2020)

Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2
por: Walls, Alexandra C., et al.
Publicado: (2020)

Process development of a SARS-CoV-2 nanoparticle vaccine
por: Martinez-Cano, Diandra, et al.
Publicado: (2023)

NVX-CoV2373, a protein-based vaccine against SARS-CoV-2 infection
por: Vohra-Miller, Sabina, et al.
Publicado: (2022)

Competitive Immunoassay of SARS-CoV-2 Using Pig Sera-Derived Anti-SARS-CoV-2 Antibodies
por: Bong, Ji-Hong, et al.
Publicado: (2021)

Nanoparticle and virus-like particle vaccine approaches against SARS-CoV-2
por: Kim, Chulwoo, et al.
Publicado: (2022)

Phylodynamic analysis revealed that human mobility and vaccination were correlated to the local spread of SARS-CoV-2 in Republic of Korea
por: Lee, Sangyi, et al.
Publicado: (2023)

Seven-Month Analysis of Five SARS-CoV-2 Antibody Assay Results after ChAdOx1 nCoV-19 Vaccination: Significant Decrease in SARS-CoV-2 Antibody Titer
por: Jeong, Seri, et al.
Publicado: (2021)

Susceptibility to SARS-CoV-2 and MERS-CoV in Beagle Dogs
por: Lyoo, Kwang-Soo, et al.
Publicado: (2023)

Olfactory and taste disorder: The first and only sign in a patient with SARS-CoV-2 pneumonia
por: Jang, Youngeun, et al.
Publicado: (2020)

Immune-mediated liver injury represented as overlap syndrome after SARS-CoV-2 vaccination
por: Lee, Soon Kyu, et al.
Publicado: (2022)

SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity
por: Joyce, M. Gordon, et al.
Publicado: (2021)

SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity
por: Joyce, M. Gordon, et al.
Publicado: (2021)

Human endogenous retrovirus-enveloped baculoviral DNA vaccines against MERS-CoV and SARS-CoV2
por: Cho, Hansam, et al.
Publicado: (2021)

Transmission and Infectious SARS-CoV-2 Shedding Kinetics in Vaccinated and Unvaccinated Individuals
por: Jung, Jiwon, et al.
Publicado: (2022)

Development of an efficient Sanger sequencing-based assay for detecting SARS-CoV-2 spike mutations
por: Lim, Ho Jae, et al.
Publicado: (2021)

Comparative genetic analyses of Korean bat coronaviruses with SARS-CoV and the newly emerged SARS-CoV-2
por: Na, Eun-Jee, et al.
Publicado: (2021)

Intramuscular administration of recombinant Newcastle disease virus expressing SARS-CoV-2 spike protein protects hACE-2 TG mice against SARS-CoV-2 infection
por: Kim, Deok-Hwan, et al.
Publicado: (2023)

Induction of neutralizing antibodies against SARS-CoV-2 variants by a multivalent mRNA-lipid nanoparticle vaccine encoding SARS-CoV-2/SARS-CoV Spike protein receptor-binding domains
por: Zhang, Qiong, et al.
Publicado: (2022)

Recombinant protein vaccines against SARS-CoV-2
por: Gilbert, Sarah C, et al.
Publicado: (2021)

Copper-Coated Polypropylene Filter Face Mask with SARS-CoV-2 Antiviral Ability
por: Jung, Sunghoon, et al.
Publicado: (2021)

Development of Spike Receptor-Binding Domain Nanoparticles as a Vaccine Candidate against SARS-CoV-2 Infection in Ferrets
por: Kim, Young-Il, et al.
Publicado: (2021)

Development of spike receptor-binding domain nanoparticle as a vaccine candidate against SARS-CoV-2 infection in ferrets
por: Kim, Young-Il, et al.
Publicado: (2021)

Breadth of SARS-CoV-2 Neutralization and Protection Induced by a Nanoparticle Vaccine
por: Li, Dapeng, et al.
Publicado: (2022)

Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine
por: Li, Dapeng, et al.
Publicado: (2022)

Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines
por: Shepherd, Sarah J., et al.
Publicado: (2023)

SARS-CoV-2: To be or not to be vaccinated?
por: Beauchet, Olivier
Publicado: (2021)

Ad26.COV2.S and SARS-CoV-2 spike protein ferritin nanoparticle vaccine protect against SARS-CoV-2 Omicron BA.5 challenge in macaques
por: Yu, Jingyou, et al.
Publicado: (2023)

Amyloidogenic proteins in the SARS-CoV and SARS-CoV-2 proteomes
por: Bhardwaj, Taniya, et al.
Publicado: (2023)

Development of a ferritin-based nanoparticle vaccine against the SARS-CoV-2 Omicron variant
por: Tai, Wanbo, et al.
Publicado: (2022)

Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
por: Keech, Cheryl, et al.
Publicado: (2020)

Rapid Biosensor of SARS-CoV-2 Using Specific Monoclonal Antibodies Recognizing Conserved Nucleocapsid Protein Epitopes
por: Lee, Jong-Hwan, et al.
Publicado: (2022)

STANDARD M10 SARS-CoV-2 Assay for Rapid Detection of SARS-CoV-2: Comparison of Four Real-Time PCR Assays
por: Jeong, Seri, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l8dnf87esbsv2d0ankon2l462c